Loading clinical trials...
Loading clinical trials...
The main objective is to assess whether there are factors associated with women's refusal to participate in a randomized clinical trial involving first-trimester screening for pre-eclampsia. The secondary objective is to qualitatively evaluate the reasons for acceptance and refusal to participate.
1. Determine the acceptance/refusal rate among all women identified, eligible and offered RCT. 2. Comparison of demographic characteristics between the two groups * Group 1: women accepting to participate in RCT * Group 2: women refusing to participate in RCT 3. Assessment of motivations for acceptance (based on questionnaire given to women who agree to participate) 4. Evaluation of reasons for refusal to participate - obstacles (based on the questionnaire given to women who refuse to participate).
Age
18 - No limit years
Sex
FEMALE
Healthy Volunteers
No
Port-Royal Maternity
Paris, IDF, France
Start Date
April 11, 2024
Primary Completion Date
October 31, 2024
Completion Date
October 31, 2024
Last Updated
September 15, 2025
472
ACTUAL participants
Questionnaire
BEHAVIORAL
Questionnaire
BEHAVIORAL
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Collaborators
NCT06273683
NCT06258902
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06689930